Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer.
PURPOSE: We aimed to identify signaling pathways involved in the response and resistance to aromatase inhibitor therapy in patients with breast cancer. PATIENTS AND METHODS: One hundred fourteen women with T2-4 N0-1, estrogen receptor (ER) alpha-positive tumors were randomly assigned to neoadjuvant...
Những tác giả chính: | Generali, D, Buffa, F, Berruti, A, Brizzi, M, Campo, L, Bonardi, S, Bersiga, A, Allevi, G, Milani, M, Aguggini, S, Papotti, M, Dogliotti, L, Bottini, A, Harris, A, Fox, S |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
2009
|
Những quyển sách tương tự
-
The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen
Bằng: Fox, S, et al.
Được phát hành: (2011) -
The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
Bằng: Fox, S, et al.
Được phát hành: (2011) -
Factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients
Bằng: Generali, D, et al.
Được phát hành: (2006) -
Principal factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients.
Bằng: Generali, D, et al.
Được phát hành: (2006) -
Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.
Bằng: Mele, T, et al.
Được phát hành: (2010)